Autopsy report · NCT05123300

PRISMA-PET - Primary Staging of Prostate Cancer With PSMA

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.

“Due to change of EAU guidelines, where PSMA-PET/CT is now recommended for primary staging of prostate cancer. We do not believe we ethically could continue this protocol, when the new examination, that was our intervention, is now the recommended.”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 3 years 4 months before it stopped.
385 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Odense University Hospital
Sponsor type: University, hospital or other
Conditions: Prostate Cancer
Interventions: 18F-PSMA-1007
Participants: 385
Sites: 3
Countries: Denmark

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.